by Sue Robbins | Dec 6, 2020 | Migraine
The COVID?19 health emergency has led many Headache providers to transition to virtual care overnight without preparation. We review our experience and discuss tips to bring humanity to the virtual visits. Introduction Human presence is intrinsically...
by Sue Robbins | Dec 6, 2020 | Migraine
Fewer Headaches Reported When School Starts Later, UCSF-Led Study Shows Research indicates that starting school later in the morning yields health and academic benefits for high schoolers, whose natural body clock tends toward late-to-bed, late-to-rise habits. While...
by Sue Robbins | Dec 1, 2020 | Migraine
How putting a program in place improved outcomes for employees with migraine Managing migraine at work can be hard for employees, but it also takes a toll on the company. That’s why Novartis, a global healthcare company based in Switzerland, launched a migraine...
by Sue Robbins | Nov 23, 2020 | Migraine
Therapy options for patients with migraines have expanded over the past couple of years, with several new drug classes specific to the disorder. Leading migraine experts discuss how they decide to choose one therapy over another. Treatment options for migraine have...
by Sue Robbins | Nov 22, 2020 | Migraine
In 2018 the FDA approved three new medications to treat migraine.1 These medications are known by the brand names Aimovig, Emgality, and Ajovy. All three medications are in a class called calcitonin gene-related peptide inhibitors (CGRPs). CGRPs developed to treat...
